证券时报e公司讯,科兴制药(688136)4月26日晚间发布一季度业绩报告,业绩增长显著,其中,营业收入3.61亿元,同比增长11.79%,归母净利润1240万元,同比扭亏为盈。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”